Skip to main content
. 2020 Jun 19;2020:9046781. doi: 10.1155/2020/9046781

Figure 3.

Figure 3

FAZ was decreased in non-iRVO, and no significant change in iRVO after 6-month therapy. ∗∗p < 0.01.